本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Travere Therapeutics, Inc.

21.15
+0.39001.88%
盤後21.150.00000.00%16:20 EDT
成交量:233.38萬
成交額:4,890.40萬
市值:18.78億
市盈率:-5.19
高:21.71
開:21.09
低:20.15
收:20.76
資料載入中...
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities